Fewer coronavirus infections among people who kept distancing People who follow the advice to stay 1.5 apart from others are less likely to contract the coronavirus SARS-CoV-2.
Coronavirus monitoring in sewage research expanded and extended Since March 2020, RIVM has been working with the water boards in the Netherlands to monitor sewage for traces of the coronavirus SARS-CoV-2. The measurements are an important supplement to other COVID-19 studies.
Fewer cases, higher percentage of positive tests In the week of 31 March to 6 April, 48,186 people in the Netherlands received a positive test result for COVID-19. That is a decrease of 7% compared to the week before.
New hold on vaccination with AstraZeneca for people under 60 years The Ministry of Health, Welfare and Sport (VWS) has decided to stop vaccinating with the COVID-19 vaccine made by AstraZeneca for people under 60 (born in 1961 or later), effectively from now until Wednesday.
People born 1947-1951 invited for COVID-19 vaccination starting 6 April Starting Tuesday 6 April, the first people in the next age group will receive an invitation from RIVM for a COVID-19 vaccination. These people were born in the years from 1947 through 1951.
Single vaccination after COVID-19 infection within the past six months Starting today, people who tested positive for COVID-19 in the past six months can indicate when scheduling a vaccination appointment that they only want one vaccine dose.
Health effects due to titanium nanoparticles in food and toothpaste cannot be excluded Health effects due to exposure to titanium dioxide nanoparticles via food, food supplements and toothpaste cannot be excluded.
Moderate flu season Last winter season, the duration and severity of the influenza epidemic was moderate compared to previous years.
Support for improving health in all policies The Health in All Policies (HiAP) approach involves multiple policy sectors collaborating for promoting and protecting population’s health and addressing health inequalities.
Assessment of health effects of alternative tobacco products To assess the effects on the health of users of alternative tobacco products, more knowledge is required about the composition of the product, the smoker’s behaviour (such as the amount of cigarett